BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.045
+0.025 (2.45%)
At close: Oct 2, 2026, 4:00 PM EDT
1.040
-0.005 (-0.48%)
After-hours: Oct 2, 2026, 4:10 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $15.74 million as of October 2, 2026. Its market cap has increased by 11.59% in one year.
Market Cap
15.74M
Enterprise Value
11.92M
1-Year Change
11.59%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $15.74M, a decrease of -45.85%. That is a compound annual growth rate of -5.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 15.74M | 18.68% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 17.01M |
| Akari Therapeutics, | 16.98M |
| Lipocine | 16.90M |
| Cellectar Biosciences | 16.82M |
| Dyadic International | 16.61M |
| Allarity Therapeutics | 16.55M |
| NewcelX | 16.46M |
| Kiora Pharmaceuticals | 16.29M |